Lebeck J, Cheema M, Skowronski M, Nielsen S, Praetorius J. Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment. Am J Physiol Gastrointest Liver Physiol. 2015;308:G198-205 pubmed publisher

Stahl K, Rahmani S, Prydz A, Skauli N, MacAulay N, Mylonakou M, et al. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease. PLoS ONE. 2018;13:e0194896 pubmed publisher

Kabutomori J, Beloto Silva O, Geyer R, Musa Aziz R. Lithobates catesbeianus (American Bullfrog) oocytes: a novel heterologous expression system for aquaporins. Biol Open. 2018;7: pubmed publisher

Rodríguez A, Moreno N, Balaguer I, Méndez Giménez L, Becerril S, Catalán V, et al. Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice. Sci Rep. 2015;5:12067 pubmed publisher

Jelen S, Parm Ulhøi B, Larsen A, Frøkiær J, Nielsen S, Rutzler M. AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytes. PLoS ONE. 2013;8:e75764 pubmed publisher

Rubenwolf P, Georgopoulos N, Kirkwood L, Baker S, Southgate J. Aquaporin expression contributes to human transurothelial permeability in vitro and is modulated by NaCl. PLoS ONE. 2012;7:e45339 pubmed publisher